Triple Drug Combination Is Promising Option To Treat Metastatic HER2+ Breast Cancer

Thursday, May 21, 2009 - 20:35 in Health & Medicine

Combining two chemotherapy drugs with trastuzumab to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net